“This partnership allows us to continue to bring new medical advancements to market and gives us a larger presence in the Midwest,” said Andrea Garcia, CRA’s vice president of new site development. “We are excited about offering new clinical research opportunities to patients in the Chicago area.”
CRA is a community-based site network that teams up with local physicians to set up clinical research sites within established medical offices. By partnering with community practices, CRA is able to facilitate the rapid recruitment of reliable and qualified trial participants. The partnerships also foster a higher level of study compliance, as CRA’s partner physicians give participants expert medical attention during the trial. During the clinical trial process, CRA’s research staff provides coordination and regulatory support for each physician. This includes providing a full execution of the protocol with complete and accurate data.
To learn more about studies taking place at this site, call 1-855-4-A-STUDY (1-855-427-8839)
About Clinical Research Advantage
Tempe, Arizona-based Clinical Research Advantage, Inc. (CRA) is the country’s largest wholly owned network of clinical trial sites. CRA works with pharmaceutical companies and contract research organizations to perform clinical trials for pharmaceuticals, vaccines and medical devices. The services provided by CRA allow trial sponsors to bring medical advancements to market quickly and efficiently. Founded in 1992, CRA acquired Radiant Research in 2012 and Comprehensive Clinical Development in 2013. Combined, the companies have successfully completed more than 11,000 clinical trials. For more information, please visit http://www.crastudies.com.